By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
SAGE Therapeutics (SAGE) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/3/2017 6:55:11 AM
SAGE Therapeutics (SAGE) Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 2/23/2017 6:27:59 AM
SAGE Therapeutics (SAGE) Takes Investors On A Wild Ride As CEO Talks Up Brain Drugs 2/22/2017 8:51:49 AM
SAGE Therapeutics (SAGE) To Report Fourth Quarter And Full Year 2016 Financial Results On Thursday, February 23, 2017 2/17/2017 6:26:11 AM
SAGE Therapeutics (SAGE) Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity 2/17/2017 6:02:21 AM
SAGE Therapeutics (SAGE) Advances SAGE-217 Into Placebo-Controlled Phase 2 Clinical Trial In Major Depressive Disorder 2/13/2017 6:26:05 AM
SAGE Therapeutics (SAGE) Announces Initiation Of Phase 2 Clinical Development For SAGE-217 In Mood Disorders 12/19/2016 10:06:22 AM
SAGE Therapeutics (SAGE) Announces Initiation Of Phase 2 Clinical Development For SAGE-217 In Movement Disorders 12/13/2016 11:18:24 AM
SAGE Therapeutics (SAGE) Announces Expedited Development Plan For SAGE-547 In The Treatment Of Postpartum Depression Based On FDA Breakthrough Therapy Meeting 12/6/2016 12:34:25 PM
SAGE Therapeutics (SAGE) Soars on Expedited Development of SAGE-547 Following Meeting With the FDA 12/6/2016 7:16:08 AM
12345678910...
//-->